Introduction en Suisse de l’inactivation des agents pathogènes pour les concentrés plaquettaires
Markus Jutzi(Swiss Red Cross), Behrouz Mansouri Taleghani(University of Bern), Morven Rüesch(Swissmedic)
Cited by 1
Related Papers
Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion
|Archives of Gynecology and Obstetrics|2019|96
Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia
|The American Journal of Medicine|2003|72
Familial Clustering of High Factor VIII Levels in Patients With Venous Thromboembolism
|Arteriosclerosis Thrombosis and Vascular Biology|2001|70
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.
|PubMed|2004|66
Oxaliplatin‐induced immune pancytopenia
|Transfusion|2005|65